1. Home
  2. AEON vs DCM Comparison

AEON vs DCM Comparison

Compare AEON & DCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AEON Biopharma Inc.

AEON

AEON Biopharma Inc.

N/A

Current Price

$0.16

Market Cap

13.0M

Sector

Health Care

ML Signal

N/A

DCM

DeFi Capital Markets Inc. Common Stock

N/A

Current Price

$3.19

Market Cap

11.7M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
AEON
DCM
Founded
N/A
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electronic Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
13.0M
11.7M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
AEON
DCM
Price
$0.16
$3.19
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $1.82
N/A
AVG Volume (30 Days)
★ 613.6K
8.3K
Earning Date
11-24-2026
01-30-2018
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $4,847,163.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.13
$2.82
52 Week High
$1.45
$4.51

Technical Indicators

Market Signals
Indicator
AEON
DCM
Relative Strength Index (RSI) 34.12 31.10
Support Level $0.13 $2.83
Resistance Level $0.33 $3.40
Average True Range (ATR) 0.03 0.29
MACD -0.01 -0.02
Stochastic Oscillator 20.78 32.99

Price Performance

Historical Comparison
AEON
DCM

About AEON AEON Biopharma Inc.

AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.

Share on Social Networks: